NCT04096638
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Phase 1
Drug Category: Therapeutic Antibody, Immunotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: 
Additional Notes: TNBC patients are only eligible for the expansion phase
Exclusions: Patients with untreated unstable brain metastases- see trial for details
https://ClinicalTrials.gov/show/NCT04096638